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92* Using insertion sequences to determine gene function in
epidemic Pseudomonas aeruginosa
D.T. Kenna, J.R. Govan, C.J. Doherty. Cystic Fibrosis Group, Centre for Infectious
Diseases, University of Edinburgh, Edinburgh, United Kingdom
Pseudomonas aeruginosa is the pathogen most commonly associated with morbidity
and mortality in cystic ﬁbrosis (CF). While most CF patients are infected with
individual P. aeruginosa strains believed to be environmental in origin, in recent
years strains that are transmissible from person to person have been emerging within
CF clinics. These epidemic strains are often atypical, many are multi-drug resistant
and some possess unusual characteristics such as an increased ability to aerosolise.
The microbial factors responsible for these characteristics are not clear. We are using
insertion sequences (IS) to investigate these factors, and to study the evolution of
these strains. IS are mobile DNA elements possessing only the genes that allow
them to move from one genomic site to another. By mapping IS to the genome we
can determine genes necessary for survival and spread of P. aeruginosa. Intragenic
insertion suggests that these particular genes are not crucial for cell survival since
their transcription will be interrupted, whereas essential genes should not contain
IS. Certain “active” IS can also act as promotors for downstream gene activation.
A genome–based study was conducted to compare IS sites in the Liverpool and
Manchester epidemic strains (LES and MAN) with those of three non-epidemic
strains. All ﬁve strains had multiple IS. However, unlike the genomes of the non-
epidemic strains, which had IS spread throughout the genome, MAN and LES had
a propensity for IS clustering. The genes immediately downstream of two active IS
in LES and MAN were determined and included homologs of glycosyl transferases
and of genes involved in oxidoreductase activity.
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Phenotypic and genotypic changes of infecting strains of P. aeruginosa play a critical
role in the establishment and maintenance of chronic lung infections in patients with
cystic ﬁbrosis (CF). In the present investigation, GeneChip P. aeruginosa Affymetrix
Genome Arrays were applied to determine the global transcriptional proﬁles of
paired mucoid and non-mucoid P. aeruginosa isolates from early and late phases of
chronic infection in four CF patients harbouring the same genotype. By comparing
the gene expression patterns in isolates from different stages of the chronic
lung infection, we found that the mucoid phenotype maintained an essentially
unaltered transcriptional proﬁle for decades, whereas substantial alterations of
the transcriptional proﬁles were observed in corresponding isolates of the non-
mucoid phenotype. The late non-mucoid isolates displayed reduced expression of
many genes involved in quorum sensing, production of virulence factors and iron
acquisition, and increased expression of genes involved in anaerobic respiration and
antibiotic resistance as compared to the early isolates. In conclusion, the conserved
gene expression pattern in the mucoid isolates versus the diversity of changes
in non-mucoid P. aeruginosa isolates reﬂects different adaptation strategies used
by these two phenotypes, possibly associated with the different requirements for
survival in speciﬁc niches of the CF airways.
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We analyzed the population diversity of Staphylococcus aureus in airway specimens
of cystic ﬁbrosis patients and in nasal colonizing situations.
The heterogeneity of S. aureus was determined by quantifying the occurrence of
phenotypic variants (differences in hemolysis, pigmentation, colony morphology) in
primary cultures from nose, oropharyngeal and sputum specimens from CF patients
and in nose swabs from healthy S. aureus carriers in 2 German Centers.
The proportion of heterogeneous samples, the number of clearly distinguishable
isolates per sample and the qualitative differences between phenotypes was sig-
niﬁcantly higher in CF sputa than in the other samples. The heterogeneity of
the S. aureus population could be correlated with high bacterial densities in the
sputum samples. Molecular analysis of heterogeneous samples by pulsed-ﬁeld gel
electrophoresis or spa-typing revealed that the bacteria were polyclonal (30%), mon-
oclonal with minor genetic alterations (25%), or not distinguishable by the genetic
typing methods used (69%). Importantly, differences in antibiotic susceptibility were
detected in phenotypic S. aureus variants within a single specimen.
Diversiﬁcation of the S. aureus population is highly favored during chronic CF lung
infection, supporting the general hypothesis that maintenance of intra-host diversity
can be of adaptive value, increasing the ﬁtness of the bacterial community.
This work was partially funded by the German CF Foundation to BCK (Mukoviszi-
dose e.V. Project F04/03) and CW (Mukoviszidose e.V. Project SH/42004−01).
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Routine microbiological analysis of CF sputum samples only provides data on
the presence or absence of a small group of bacterial species. Recent molecular-
based studies have suggested that the bacterial community in CF sputum is far
more complex than previously believed, with a number of species candidates for
inclusion in routine surveillance. Here we compare the T-RFLP proﬁles generated
directly from 8 adult CF sputum samples with those generated from an array of
standard culture plates from the same samples.
The proﬁles generated from culture and sputum differed signiﬁcantly, with a higher
number of bands, and a greater phylogenetic range, resolved from the sputa.
On average 14.4 (+10.8) bands were detected per sputum proﬁle, compared with
8.5 (+5.4) bands per culture proﬁle, with a total of 74 separate T-RF band lengths
detected in the proﬁles arising directly from sputum, compared with 31 in the
proﬁles arising from cultures. There were 78 instances of bands being detected
in the T-RFLP proﬁle from the sputum that were not detected in the proﬁles
based on routine culture. In total, 60.5% of all the T-RF lengths detected were
detected in sputum proﬁles alone. Further, there were signiﬁcant differences in the
predominance of species between the two sample types, with a total of 15 instances
of T-RF bands detected in the sputum DNA proﬁle alone that represented more
than 10% of the total band volume.
These data highlight the highly selective nature of culture-based microbial surveil-
lance and suggest a thorough molecular-based survey of the bacterial species present
in CF lung infections would be of great value in identifying previously unrecognised
CF pathogens.
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